CoChat

Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 35 of the 44 sources its claims cite were checked for support.

Abstract

This study found that orally and intravenously administered NMN and NR undergo degradation pathways including conversion to nicotinamide and deamidation to nicotinic acid-related metabolites.

Overview

CoChat Summary

## TL;DR

In mice, orally administered NMN and NR were only partly directly absorbed; most were converted by gut microbiota into nicotinic acid and then used to make NAD+ in the liver via the Preiss-Handler pathway. The study also found that intravenously administered NMN and NR were degraded to nicotinamide, secreted into bile, converted by gut microbiota, and routed back through enterohepatic circulation.

## Key findings

  • After oral gavage, NMN significantly increased NMN levels in the small intestine at 15 min, while NR produced a much smaller rise, about 25-fold less than NMN; small-intestine NAD+ peaked at 15–30 min.
  • In WT mice, oral NMN and NR increased hepatic deamidated metabolites (NAAD, NAMN, NAR) at 3–6 hours; in germ-free mice, these deamidated metabolites did not increase and hepatic NAD+ rise was significantly suppressed.
  • In Naprt KO mice, oral NMN failed to increase hepatic NAAD, NAMN, and NAR, and hepatic NAD+ rise was significantly suppressed, showing that NMN-derived NAD+ synthesis in the liver depends mainly on the Preiss-Handler pathway.
  • Stable-isotope tracing showed that orally administered [m+6] NR and [m+8] NMN produced only small amounts of labeled NAD+, while most increased NAD+ in liver and skeletal muscle was labeled as [m+1], [m+3], or [m+4], consistent with conversion through NAM/NA rather than direct precursor use.
  • After intravenous injection, NR and NMN increased liver and skeletal muscle NAD+ at 3 hours, but antibiotic treatment abolished the rise in NAAD, NAMN, and NAR and reduced liver NAD+, indicating a gut microbiota contribution even for injected precursors; bile duct ligation significantly suppressed hepatic NAAD and reduced NMN-driven liver NAD+ (with P = 0.0533 for an interaction trend).

## Methods

  • Mouse in vivo metabolomics study using WT C57BL/6N, germ-free, Naprt KO, and antibiotic-treated mice; interventions included single oral gavage, 2-week repeated gavage, intravenous injection, and bile duct ligation.
  • Doses included 1.57 mmol/kg NR chloride or NMN for single gavage/injection; repeated gavage used 131 mg/kg NMN for 2 weeks.
  • Main analysis was NAD+ metabolomics by LC-MS/MS in liver, skeletal muscle (gastrocnemius), small intestine, large intestine, serum, bile, and portal blood, plus stable-isotope tracing with [m+6] NR, [m+8] NMN, and [m+4] NAM.

## Limitations

  • The paper states that it remains unknown whether the route of secretion from blood to the gastrointestinal tract is via bile and that the detailed mechanisms of NAM/NR transport into bile are unknown.
  • The paper states that it remains unclear whether human in vivo NAD+ metabolism is the same as in mice.
  • The paper states that the contribution of direct NAD+ synthesis from NR or NMN during long-term administration remains unknown; evident from the text: several conclusions are based on mouse models and short time windows after dosing, so translation to humans and chronic use is not established.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1126/sciadv.adr1538

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Orally administered NMN and NR were directly taken up from the small intestine. (A) Overview of NAD+ biosynthesis pathways in mammals. (B) Time course analysis of NAD+ metabolome in the small intestine of WT mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NMN < 0.0001, NR = 0.0022, NAD+ = 0.2128, NAAD < 0.0001, and NAMN < 0.0001. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05 and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. Daggers (†P < 0.05, ††P < 0.01, and †††P < 0.001) indicate significance compared with the saline group at the same time point in the specific time point analysis. (C) Time course analysis of NAD+ metabolome in A549 cells treated with NMN and NR. n = 3 to 4. P values of interaction effect; NMN < 0.0001, NR < 0.0001, and NAD+ = 0.0032. Statistical significance was determined by Tukey’s test. Asterisks (***P < 0.001 and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. Daggers (†P < 0.05 and ††P < 0.01) indicate significance compared with the saline group at the same time point in the specific time point analysis. (D) Effect of CD73 knockdown on NAD+ metabolome in A549 cells treated with NMN. n = 4. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, and ***P < 0.001). h, hours.
Fig. 1. Orally administered NMN and NR were directly taken up from the small intestine. (A) Overview of NAD+ biosynthesis pathways in mammals. (B) Time course analysis of NAD+ metabolome in the small intestine of WT mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NMN < 0.0001, NR = 0.0022, NAD+ = 0.2128, NAAD < 0.0001, and NAMN < 0.0001. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05 and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. Daggers (†P < 0.05, ††P < 0.01, and †††P < 0.001) indicate significance compared with the saline group at the same time point in the specific time point analysis. (C) Time course analysis of NAD+ metabolome in A549 cells treated with NMN and NR. n = 3 to 4. P values of interaction effect; NMN < 0.0001, NR < 0.0001, and NAD+ = 0.0032. Statistical significance was determined by Tukey’s test. Asterisks (***P < 0.001 and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. Daggers (†P < 0.05 and ††P < 0.01) indicate significance compared with the saline group at the same time point in the specific time point analysis. (D) Effect of CD73 knockdown on NAD+ metabolome in A549 cells treated with NMN. n = 4. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, and ***P < 0.001). h, hours.CC BY-NC · PubMed Central
Fig. 2. Gut microbiota and Preiss-Handler pathway are essential for orally administered NMN to increase NAD+ levels in the liver. (A) Time course analysis of NAD+ metabolome in the liver of WT mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NR < 0.0001, NMN < 0.0001, NAM < 0.0001, NAAD < 0.0001, NAR < 0.0001, NAMN < 0.0001, and NA = 0.0777. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. (B) NAD+ metabolome in the liver of control and germ-free mice at 3 hours after the oral administration of NMN and NR. n = 3 to 4 mice per group. P values of interaction effect; NA = 0.0007, NAR = 0.0069, NAAD < 0.0001, and NAD+ < 0.0001. Statistical significance was determined by Tukey’s test (**P < 0.01). (C) NAD+ metabolome in the blood from the portal vein of control and germ-free mice at 3 hours after the oral administration of NMN and NR. n = 4 mice per group. P values of interaction effect; NA = 0.0024, NAM = 0.9063, NR = 0.8483, and NMN = 0.2144. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (D) NAD+ metabolome in the liver of WT and Naprt KO mice at 3 hours after the oral administration of NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NAAD < 0.0001, NAMN < 0.0001, NAR < 0.0001, NA < 0.0001, NAM < 0.0001, NR = 0.0448, and NMN < 0.0001. Statistical significance was determined by Tukey’s test (**P < 0.01).
Fig. 2. Gut microbiota and Preiss-Handler pathway are essential for orally administered NMN to increase NAD+ levels in the liver. (A) Time course analysis of NAD+ metabolome in the liver of WT mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NR < 0.0001, NMN < 0.0001, NAM < 0.0001, NAAD < 0.0001, NAR < 0.0001, NAMN < 0.0001, and NA = 0.0777. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001) indicate significance compared with the saline group at the same time point in the overall analysis. (B) NAD+ metabolome in the liver of control and germ-free mice at 3 hours after the oral administration of NMN and NR. n = 3 to 4 mice per group. P values of interaction effect; NA = 0.0007, NAR = 0.0069, NAAD < 0.0001, and NAD+ < 0.0001. Statistical significance was determined by Tukey’s test (**P < 0.01). (C) NAD+ metabolome in the blood from the portal vein of control and germ-free mice at 3 hours after the oral administration of NMN and NR. n = 4 mice per group. P values of interaction effect; NA = 0.0024, NAM = 0.9063, NR = 0.8483, and NMN = 0.2144. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (D) NAD+ metabolome in the liver of WT and Naprt KO mice at 3 hours after the oral administration of NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NAAD < 0.0001, NAMN < 0.0001, NAR < 0.0001, NA < 0.0001, NAM < 0.0001, NR = 0.0448, and NMN < 0.0001. Statistical significance was determined by Tukey’s test (**P < 0.01).CC BY-NC · PubMed Central
Fig. 3. Tracing of orally administered stable isotope–labeled NMN and NR revealed that NAD+ synthesis through gut microbiota and Preiss-Handler pathway was the major route in the liver. (A) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 6] NR. (B) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 6] NR. n = 5 mice for saline group and n = 4 mice for NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NMN. (D) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 mice for saline group and n = 4 mice for NMN-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Fig. 3. Tracing of orally administered stable isotope–labeled NMN and NR revealed that NAD+ synthesis through gut microbiota and Preiss-Handler pathway was the major route in the liver. (A) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 6] NR. (B) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 6] NR. n = 5 mice for saline group and n = 4 mice for NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NMN. (D) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 mice for saline group and n = 4 mice for NMN-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).CC BY-NC · PubMed Central
Fig. 4. NAM cleaved from orally administered NR and NMN was preferentially used for NAD+ synthesis in the skeletal muscle. (A) Time course analysis of muscle NAD+ metabolome in mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NR < 0.0001, NMN = 0.0020, NAM = 0.0002, NAAD < 0.0001, NAR < 0.0001, NAMN < 0.0001, and NA = 0.1543. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001) indicate significance versus the saline group at the same time point in the overall analysis, while daggers (†P < 0.05) indicate significance in the specific time point analysis. (B) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 6] NR. n = 5 (saline group) and n = 4 (NR group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 (saline group) and n = 4 (NMN group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) Muscle NAD+ metabolome in WT and Naprt KO mice at 3 hours after the oral administration of NMN and NR. n = 4 to 6 mice per group. P values of interaction effect; NAD+ = 0.5991, NR = 0.7034, NMN = 0.6969, NAM = 0.9819, NAAD < 0.0001, NAR < 0.0001, and NA = 0.0885. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Fig. 4. NAM cleaved from orally administered NR and NMN was preferentially used for NAD+ synthesis in the skeletal muscle. (A) Time course analysis of muscle NAD+ metabolome in mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NR < 0.0001, NMN = 0.0020, NAM = 0.0002, NAAD < 0.0001, NAR < 0.0001, NAMN < 0.0001, and NA = 0.1543. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001) indicate significance versus the saline group at the same time point in the overall analysis, while daggers (†P < 0.05) indicate significance in the specific time point analysis. (B) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 6] NR. n = 5 (saline group) and n = 4 (NR group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 (saline group) and n = 4 (NMN group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) Muscle NAD+ metabolome in WT and Naprt KO mice at 3 hours after the oral administration of NMN and NR. n = 4 to 6 mice per group. P values of interaction effect; NAD+ = 0.5991, NR = 0.7034, NMN = 0.6969, NAM = 0.9819, NAAD < 0.0001, NAR < 0.0001, and NA = 0.0885. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).CC BY-NC · PubMed Central
Fig. 5. Intravenous injection of NR and NMN elevated deamidated NAD+ metabolites in the liver through gut microbiota. (A) Time course analysis of serum NAD+ metabolome in mice intravenously injected with NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NR = 0.0002, NMN = 0.0018, and NAM < 0.0001. Asterisks indicate significance versus saline group at the same time point. (B and C) NAD+ metabolome in the liver (B) and muscle (C) from WT mice at 3 hours after the intravenous injection of NMN and NR. n = 6 (saline group) and n = 9 (NR or NMN groups). (D) Liver NAD+ metabolome in control and Abx-treated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 7 mice per group. P values of interaction effect; NAD+ < 0.0001, NAAD = 0.0118. (E) Muscle NAD+ metabolome in control and Abx-treated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 7 mice per group. P values of interaction effect; NAD+ = 0.2939 and NAAD < 0.0001. (F) Muscle NAD+ metabolome in WT and Naprt KO mice at 3 hours after the intravenous injection of NMN and NR. n = 5 to 9 mice per group. P values of interaction effect; NAD+ = 0.0124, NAAD = 0.0792, NR = 0.4316, and NMN = 0.9108. (G) Liver NAD+ metabolome in WT and Naprt KO mice at 3 hours after the intravenous injection of NMN and NR. n = 5 to 9 mice per group. P values of interaction effect; NAD+ = 0.024, NAAD = 0.0622, NR = 0.0031, and NMN = 0.0016. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Fig. 5. Intravenous injection of NR and NMN elevated deamidated NAD+ metabolites in the liver through gut microbiota. (A) Time course analysis of serum NAD+ metabolome in mice intravenously injected with NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NR = 0.0002, NMN = 0.0018, and NAM < 0.0001. Asterisks indicate significance versus saline group at the same time point. (B and C) NAD+ metabolome in the liver (B) and muscle (C) from WT mice at 3 hours after the intravenous injection of NMN and NR. n = 6 (saline group) and n = 9 (NR or NMN groups). (D) Liver NAD+ metabolome in control and Abx-treated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 7 mice per group. P values of interaction effect; NAD+ < 0.0001, NAAD = 0.0118. (E) Muscle NAD+ metabolome in control and Abx-treated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 7 mice per group. P values of interaction effect; NAD+ = 0.2939 and NAAD < 0.0001. (F) Muscle NAD+ metabolome in WT and Naprt KO mice at 3 hours after the intravenous injection of NMN and NR. n = 5 to 9 mice per group. P values of interaction effect; NAD+ = 0.0124, NAAD = 0.0792, NR = 0.4316, and NMN = 0.9108. (G) Liver NAD+ metabolome in WT and Naprt KO mice at 3 hours after the intravenous injection of NMN and NR. n = 5 to 9 mice per group. P values of interaction effect; NAD+ = 0.024, NAAD = 0.0622, NR = 0.0031, and NMN = 0.0016. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).CC BY-NC · PubMed Central
Fig. 6. NR is taken up by muscle and partially contributes to NAD+ synthesis. (A) NAD+ metabolome in muscle at 30 and 180 min after intravenous injection of nonlabeled NR. n = 4 mice for 30 min and n = 5 mice for 180 min. NAD+ = 0.0055, NR = 0.0078, NMN = 0.0960, NAM = 0.0187, NAAD = 0.0003, NAR = 0.4023, NAMN = 0.3484, and NA = 0.0604. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, and ****P < 0.0001). (B) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NR. (C) NAD+ metabolome in the liver at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) NAD+ metabolome in the muscle at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Fig. 6. NR is taken up by muscle and partially contributes to NAD+ synthesis. (A) NAD+ metabolome in muscle at 30 and 180 min after intravenous injection of nonlabeled NR. n = 4 mice for 30 min and n = 5 mice for 180 min. NAD+ = 0.0055, NR = 0.0078, NMN = 0.0960, NAM = 0.0187, NAAD = 0.0003, NAR = 0.4023, NAMN = 0.3484, and NA = 0.0604. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, and ****P < 0.0001). (B) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NR. (C) NAD+ metabolome in the liver at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) NAD+ metabolome in the muscle at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).CC BY-NC · PubMed Central
Fig. 7. Enterohepatic circulation of NAD+ precursors was important for NAD+ synthesis in the liver. (A) NAD+ metabolome in the bile of WT mice under normal conditions. n = 8 mice. (B) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of NMN and NR. n = 8 to 10 mice per group. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the intravenous injection of [m + 4] NAM. (D) NAD+ metabolome in the liver of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for saline group and n = 11 mice for NAM-treated group. Statistical significance was determined by Student’s t test (****P < 0.0001). (E) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for the saline group and n = 10 mice for the NAM-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (F) NAD+ metabolome in the liver of sham- and bile duct ligation (BDL)–operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.0533 and NAAD = 0.0201. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (G) NAD+ levels in the skeletal muscle of sham- and BDL-operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.3869. Statistical significance was determined by Tukey’s test.
Fig. 7. Enterohepatic circulation of NAD+ precursors was important for NAD+ synthesis in the liver. (A) NAD+ metabolome in the bile of WT mice under normal conditions. n = 8 mice. (B) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of NMN and NR. n = 8 to 10 mice per group. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the intravenous injection of [m + 4] NAM. (D) NAD+ metabolome in the liver of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for saline group and n = 11 mice for NAM-treated group. Statistical significance was determined by Student’s t test (****P < 0.0001). (E) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for the saline group and n = 10 mice for the NAM-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (F) NAD+ metabolome in the liver of sham- and bile duct ligation (BDL)–operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.0533 and NAAD = 0.0201. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (G) NAD+ levels in the skeletal muscle of sham- and BDL-operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.3869. Statistical significance was determined by Tukey’s test.CC BY-NC · PubMed Central
Fig. 8. Overview of NAD+ metabolism in the liver and skeletal muscle after oral and intravenous administration of NMN and NR. The metabolic pathways of orally administered NMN and NR are noted in red, and those of intravenously administered NMN and NR are noted in blue. The shared pathways are in green. The solid and dashed lines note the major and minor routes, respectively.
Fig. 8. Overview of NAD+ metabolism in the liver and skeletal muscle after oral and intravenous administration of NMN and NR. The metabolic pathways of orally administered NMN and NR are noted in red, and those of intravenously administered NMN and NR are noted in blue. The shared pathways are in green. The solid and dashed lines note the major and minor routes, respectively.CC BY-NC · PubMed Central

Verification

Claims the paper makes

20 Valid · 3 Not valid · 1 Not checked · 149 Own results and interpretations

118 more claims · 8 with their cited sources checked

Create a free account to see all 173 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 41
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 66 references

Cited by

Metadata

Authors
Yaku, K., Palikhe, S., Iqbal, T., Hayat, F., Watanabe, Y., Fujisaka, S., Izumi, H., Yoshida, T., Karim, M., Uchida, H., Nawaz, A., Tobe, K., Mori, H., Migaud, M. E., & Nakagawa, T.
Affiliations
  • University of Toyama (JP)
  • USA Mitchell Cancer Institute (US)
  • Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.
Corresponding author
  • Yaku, Keisuke
  • Palikhe, Sailesh
  • Nakagawa, Takashi
Venue
Science Advances
Published
2025-03-21
Volume
11
Issue
12
Pages
eadr1538-eadr1538
ISSN
2375-2548 (ISSN-L)
OpenAlex
W4408718208
Cited by
40
References
65
Citations by year
2026: 30 · 2025: 10
FWCI
23.94
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc)
Funders
Japan Society for the Promotion of Science (23K24762, 23K09644)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
Keywords
nicotinamide riboside, nicotinamide mononucleotide, NAD+ synthesis, enterohepatic circulation, gut microbiota, deamidation, nicotinic acid, NAD+ precursors, oral and intravenous administration, aging, bile secretion, nicotinamide
MeSH terms
Gastrointestinal Microbiome, Administration, Oral, Animals, Liver, Male, Mice, Inbred C57BL, NAD, Niacinamide, Nicotinamide Mononucleotide, Pyridinium Compounds, Mice, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.